DOMAIN Therapeutics
ID: 5291568A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
5
Funding Rounds
$98.6m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne****** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne****** |
|
- | |
| Em****** Fi******** | - | - | - |
| Sy**** Ry******** | - | - | - |
| Yo***** L. Be***** | - | - | - |
| Ro***** De Po*** | - | - | - |
| La****** Ru***** | - | - | - |
| Ja*** Hu*** | - | - |
Funding
Funding series
Funding Series Analysis
The company DOMAIN Therapeutics has raised a total of $56.56m in funding over 5 rounds.
Key Insights:
- DOMAIN Therapeutics Series A round, May 2022: $42m
- DOMAIN Therapeutics , May 2019: $3.9m
- DOMAIN Therapeutics funding round, July 2012: $2.46m
- DOMAIN Therapeutics Series C round Funding Round 2006: $8.2m
- Domain Therapeutics 2022 Funding Round: $42m
Industries
DOMAIN Therapeutics is active in the following industries: